UnitedHealth Group Inc. - Q1 2007 10-Q Summary
Business Context and Reporting Period
This filing is a Quarterly Report on Form 10-Q for UnitedHealth Group Inc. for the period ended March 31, 2007. The Company is a diversified health care company operating through four primary segments: Health Care Services, Uniprise, Specialized Care Services, and Ingenix. As of April 30, 2007, there were approximately 1.34 billion shares of common stock outstanding.
Key Financial Metrics
| Metric (in millions, except per share) | Q1 2007 | Q1 2006 |
|---|---|---|
| Total Revenues | $19,047 | $17,581 |
| Net Earnings | $927 | $891 |
| Diluted EPS | $0.66 | $0.63 |
| Operating Cash Flow | $2,588 | $2,890 |
| Medical Care Ratio | 82.7% | 82.1% |
| Operating Cost Ratio | 14.0% | 14.4% |
| Total Debt (Carrying Value) | $7,054 | $7,456 |
| Cash and Investments | $22,878 | $20,555 (Est.) |
Material Changes vs. Prior Period
- Revenue Growth: Consolidated revenues increased 8% year-over-year, driven by rate increases, growth in individuals served, and expansion of the Medicare Part D program.
- Profitability: Net earnings rose 4% to $927 million. Earnings from operations increased 7% to $1.582 billion.
- Medical Costs: The medical care ratio increased to 82.7% from 82.1%. This was primarily due to a shift from favorable medical cost development in Q1 2006 to unfavorable development in Q1 2007 within the UnitedHealthcare commercial business, partially offset by favorable trends in Ovations Medicare programs.
- Operating Costs: Operating costs increased 5% to $2.664 billion. This increase was significantly impacted by a $176 million expense related to Section 409A of the Internal Revenue Code regarding historic stock option practices.
- Cash Flow: Operating cash flows decreased 10% to $2.6 billion, largely due to a reduction in working capital driven by growth in Medicare Part D risk-share receivables.
Guidance, Outlook, Risks, and Unusual Items
- Section 409A Expense: The Company recorded a $176 million charge ($112 million net of tax) related to historic stock option practices. This included payments for employee tax obligations and modifications to unexercised options for nonexecutive officers.
- Acquisitions: On March 12, 2007, the Company announced a definitive agreement to acquire Sierra Health Services, Inc. for approximately $2.6 billion in cash. The transaction is expected to close prior to the end of 2007.
- Legal and Regulatory Risks: The Company faces ongoing regulatory inquiries (SEC, IRS, U.S. Attorney, Minnesota Attorney General) and litigation regarding historic stock option practices. There is a risk of fines, penalties, or further restatements.
- Debt Default Dispute: The Company is engaged in litigation regarding a purported notice of default and acceleration of $850 million in Senior Unsecured Notes due to a delayed 10-Q filing in 2006. The Company filed for a declaratory judgment stating it is not in default.
- Medicare Part D: Due to the benefit design, the Company incurs disproportionate costs in the first half of the year. A net risk-share receivable of $206 million was recorded from CMS as of March 31, 2007.
Investor Verification Checklist
- Stock Option Litigation Status: Monitor the outcome of the declaratory judgment action regarding the $850 million debt acceleration and the resolution of SEC/IRS inquiries into stock option practices.
- Medical Cost Development: Verify the trend of medical cost development in the commercial risk-based business, as unfavorable development significantly impacted the Q1 medical care ratio.
- Sierra Health Services Acquisition: Track regulatory approvals and closing conditions for the $2.6 billion acquisition of Sierra Health Services.
- Section 409A Cash Outflows: Confirm the timing and total amount of future cash payments related to the Section 409A modification of stock options (estimated aggregate payments of $150 million).
- Debt Covenants: Ensure continued compliance with debt covenants, specifically the debt-to-total-capital ratio requirement of below 50% (currently at 25.1%).